[go: up one dir, main page]

Gomes et al., 2006 - Google Patents

Comparison of antagonistic ability against enteropathogens by G+ and G− anaerobic dominant components of human fecal microbiota

Gomes et al., 2006

View PDF
Document ID
5737404503976105070
Author
Gomes D
Souza A
Lopes R
Nunes A
Nicoli J
Publication year
Publication venue
Folia microbiologica

External Links

Snippet

To confirm if anaerobic G+-components are those responsible for the function of colonization resistance, obligate anaerobic G+-and G−-bacteria from normal dominant microbiota of human feces were isolated from three successive collections and then used in in vitro …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—PROCESSES USING MICRO-ORGANISMS
    • C12R1/00—Processes using micro-organisms
    • C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
    • C12R1/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
AU2017285211B2 (en) Treatment of clostridium difficile infection
Thirabunyanon et al. Protection activity of a novel probiotic strain of Bacillus subtilis against Salmonella Enteritidis infection
Gagnon et al. In vitro inhibition of Escherichia coli O157: H7 by bifidobacterial strains of human origin
Taheur et al. Anti-bacterial and anti-biofilm activity of probiotic bacteria against oral pathogens
García-Hernández et al. Isolation, characterization and evaluation of probiotic lactic acid bacteria for potential use in animal production
Bujalance et al. A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice
Blajman et al. In vitro and in vivo screening of native lactic acid bacteria toward their selection as a probiotic in broiler chickens
Dabour et al. In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes
Collado et al. Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion
Conway Selection criteria for probiotic microorganisms
Zhang et al. Adhesive ability means inhibition activities for lactobacillus against pathogens and S-layer protein plays an important role in adhesion
Manzoor et al. Efficacy of locally isolated lactic acid bacteria against antibiotic-resistant uropathogens
CA2787544C (en) Probiotic composition for use in the treatment of bowel inflammation
CN102458426B (en) Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
NO316644B1 (en) Lactobacillus strains of human origin, mixtures and their use
Zivkovic et al. Capability of exopolysaccharide-producing Lactobacillus paraplantarum BGCG11 and its non-producing isogenic strain NB1, to counteract the effect of enteropathogens upon the epithelial cell line HT29-MTX
Mansour et al. Inhibition of Clostridium difficile in mice using a mixture of potential probiotic strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel candidates to control C. difficile infection (CDI)
KR20150143803A (en) Composition containing bacterium belonging to genus lactobacillus
Saarela et al. Safety aspects of Lactobacillus and Bifidobacterium species originating from human oro-gastrointestinal tract or from probiotic products
Pato et al. Antibiotic resistance and antibacterial activity of dadih originated Lactobacillus casei subsp. casei R-68 against food borne pathogens
Fakhry et al. Characterization of intestinal bacteria tightly bound to the human ileal epithelium
Strompfová et al. Lactobacilli and enterococci—potential probiotics for dogs
Gomes et al. Comparison of antagonistic ability against enteropathogens by G+ and G− anaerobic dominant components of human fecal microbiota
Nord et al. Oral supplementation with lactic acid-producing bacteria during intake of clindamycin
Mikelsaar Human microbial ecology: lactobacilli, probiotics, selective decontamination